Dr Sarah Mackie is an academic rheumatologist based in Leeds, UK. Her research interests are giant cell arteritis (GCA) and polymyalgia rheumatica (PMR).

She is first author of the 2020 British Society for Rheumatology guideline on giant cell arteritis. Her team won a 2022 British Society for Rheumatology Best Practice award for their GCA diagnostic pathway. She is Co-Chair of the Outcome Measures in PMR Working Group which has produced a Core Domain Set for clinical trials in PMR. She is Chief Investigator of the STERLING-PMR trial.